Advertise on podcast: National Pharmaceutical Congress (NPC) Podcast

Co-Chairman of BridgeBright Advisors’ Mike Cloutier discusses leadership at scale, leadership in the current political climate, and the hardware for being a successful leader. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

Pangaea Consultants’ Managing Director Jeff Martens discusses going from an operating role to consulting, lack of access in today’s political climate, and doing less with more. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

Seaford President Tamara Seales discusses navigating Canadian pharma regulations, team-building, and weaving DEI into the fabric of the company. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

Mike Exton, CEO and Board Director of Lexicon Pharmaceuticals, talks about safeguards and limits for AI, smaller pharma veresus big pharma, and brand strategies based on data over belief. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

Gordon McCauley, CEO of adMare BioInnovations, unpacks the profits, principles, and policies shaping today’s life sci industry. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

Casey James Lawton, General Manager at Peirre Fabre Dermo-Cosmetic, talks about diverse career experiences, learning to pivot, and building strong, science-driven foundations. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

Fatih Yetikardes, Country Manager of Daiichi Sankyo, gives insights into advancing patient care with company collaborations, the unique complexities of the Canadian healthcare system, and the ethical use and transparent governance of AI. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

Bob McLay, General Manager of Sobi Canada, gives insights into stewarding rare drug therapies, KOL advocacy and the future of preventative medicine. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

Marc Shenouda, CEO and Co-Founder of Neuropeutics Inc., gives insights into targeted therapeutics for neurodegenerative disease, winning the AbbVie Biotech Innovator’s Award, and earlier detection for ALS. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

Dr. Bettina Hamelin, President of Innovative Medicines Canada, gives insights into the adoption of innovative technologies, domestic supply chain for pharmaceuticals, and excluding medicines as retaliatory measures for tariffs. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

Paul Levesque, President and CEO of Theratechnologies Inc., gives insights into innovation in biopharma, the effects of tariffs on supply chain and pharma manufacturing, and cross-border business development. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

Mark Nawacki, President and CEO of Searchlight Pharma, gives insights into starting a specialty pharma business, therapeutics for women’s health and migraine relief, and the shift to more personalized medicines in healthcare. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

Lisa Mullett, Senior Vice-President of Sumitomo Pharma America, gives insights into the importance of diversity in companies and patient trials, stepping out of your comfort zone to further your career, and accelerating development with AI. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

Tom Slowe, CEO of Breadcrumb Analytics, gives insights into using AI to sort and sift through statistics, the importance of context with data, and why AI should only be supplementary to human work. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

Kenneth Custer, President and General Manager of Eli Lilly Canada, gives insights into his background in neuroscience, innovation in healthcare, and progress in therapeutics for obesity and Alzheimer’s. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe